上海交通大学医学院附属瑞金医院是位于中国上海市黄浦区瑞金二路197号的一所三级甲等医院。

During the past decade, Ruijin Hospital, Shanghai Jiaotong University School of Medicine conducted 518 clinical trials. In the 10-year time frame, 518 clinical trials started and 59 clinical trials were completed, i.e. on average, 11.4% percent of trials that started reached the finish line to date. In the past 5 years, 315 clinical trials started and 41 clinical trials were completed. i.e. 13% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ruijin Hospital, Shanghai Jiaotong University School of Medicine" #1 sponsor was "Ruijin Hospital" with 196 trials, followed by "Shanghai Jiao Tong University School of Medicine" with 70 trials sponsored, "Hoffmann-La Roche" with 20 trials sponsored, "Janssen Research & Development, LLC" with 18 trials sponsored and "BeiGene" with 18 trials sponsored. Other sponsors include 315 different institutions and companies that sponsored additional 181 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ruijin Hospital, Shanghai Jiaotong University School of Medicine" #1 collaborator was "Ruijin Hospital" with 48 trials as a collaborator, "Shanghai Zhongshan Hospital" with 20 trials as a collaborator, "RenJi Hospital" with 18 trials as a collaborator, "Peking University First Hospital" with 12 trials as a collaborator and "Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine" with 11 trials as a collaborator. Other collaborators include 826 different institutions and companies that were collaborators in the rest 435 trials.

According to Clinical.Site data, the most researched conditions in "Ruijin Hospital, Shanghai Jiaotong University School of Medicine" are "Breast Cancer" (21 trials), "Chronic Hepatitis B" (17 trials), "Coronary Artery Disease" (15 trials), "Hypertension" (14 trials) and "Multiple Myeloma" (14 trials). Many other conditions were trialed in "Ruijin Hospital, Shanghai Jiaotong University School of Medicine" in a lesser frequency.

Most popular intervention types in "Ruijin Hospital, Shanghai Jiaotong University School of Medicine" are "Drug" (395 trials), "Procedure" (57 trials), "Other" (52 trials), "Device" (42 trials) and "Biological" (28 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (62 trials), "Rituximab" (19 trials), "Cyclophosphamide" (17 trials), "Prednisone" (14 trials) and "Dexamethasone" (11 trials). Other intervention names were less common.

The vast majority of trials in "Ruijin Hospital, Shanghai Jiaotong University School of Medicine" are 605 trials for "All" genders, 25 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are 308 active trials in "Ruijin Hospital, Shanghai Jiaotong University School of Medicine". 27 are not yet recruiting, 215 are recruiting, 63 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 162 completed trials in Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 4 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 55 "Phase 1" clinical trials were conducted, 150 "Phase 2" clinical trials and 160 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 75 trials, and there were also 107 trials that are defined as “Not Applicable".